As Principal Consultant at Stratenym, Moez brings over five years of experience in pharmaceutical strategy, value demonstration, and advanced modelling. Prior to joining Stratenym, he served as Associate Director at a global life sciences consultancy, where he led high-impact initiatives for leading pharmaceutical companies.
His expertise spans pricing strategy, economic modelling, and evidence generation, enabling successful reimbursement and market positioning from launch through late lifecycle. Moez has worked across global markets (e.g., Europe, North America, and Asia) and brings deep experience navigating rigorous HTA landscapes. His work spans oncology, immunology, and rare diseases.
Renowned for his analytical rigor and problem-solving acumen, Moez has guided critical decision-making on complex portfolio challenges, including internal market cannibalization, revenue optimization, and product positioning.